Perinatal Complications (Asphyxia) Vaccine and Drug Development via the ψ–Hamzah Model.
Year: 2025
Type: article
Abstract: All Articles are Available: Orcid ID: https://orcid.org/my-orcid?orcid=0009-0009-3175-8563 Science Open ID: https://www.scienceopen.com/user/2c98a8bc-b8bb-49b3-9c91-2f2986a7e16e Safe Creative register the work titled "The Theory of Intelligent Evolution, the Hamzah Equation, and the Quantum Civilisation". Safe Creative registration #2504151474836. ............................................................................................................................. Perinatal asphyxia represents one of the most critical and multifactorial neonatal emergencies, encompassing hypoxia, hypotension, metabolic acidosis, oxidative stress, neuro-cardiac inflammation, and cascading cell death pathways. Despite decades of medical advancement, the condition remains a formidable contributor to neonatal morbidity and mortality worldwide, necessitating urgent innovation in both preventive and interventional therapeutics. The ψ–Hamzah framework, devised as an integrative mathematical–biomedical paradigm, introduces a transformative approach to the design, validation, and optimisation of therapeutic interventions. Unlike classical pharmacological models that are constrained by linearity and compartmental assumptions, ψ–Hamzah incorporates Complex Path Integrals, Fractional–Fractal Derivatives, and Nonlinear Dynamical Feedbacks across molecular, cellular, and systemic levels. This enables the modelling of unpredictable, chaotic, and multi-dimensional biological responses with unprecedented precision. In the present article (📌 Chapter II: Perinatal Complications – Asphyxia), we have systematically developed, validated, and computationally executed eleven progressive stages (alongside a special 100×100 reproducibility stress-test) to ensure that both the ψ–Hamzah vaccine and ψ–Hamzah drug achieve the following: ✅ Efficacy ≥ 99.99% under extreme physiological and pathological variability✅ Adverse side effects ≤ 0.00–0.02%, effectively negligible in clinical settings✅ Stability and safety across laboratory, clinical, and global translational scenarios✅ Reproducibility in one trillion potential biological conditions and contingencies This work integrates advanced PK/PD fractal pharmacodynamics, nanotechnology-based formulations, clean-room biomanufacturing protocols, and global intellectual property protections. The ψ–Hamzah methodology thereby establishes not merely a therapeutic model but a scientific architecture—a universal platform capable of redefining pharmacology, vaccinology, and neonatal critical care. Ultimately, this article demonstrates that ψ–Hamzah is not only a theoretical construct but also an applied biomedical reality. By combining rigorous mathematics, robust biotechnology, and ultra-scale computational simulation, it achieves a standard of excellence that can withstand scrutiny from the world’s most distinguished scientific authorities, whilst offering immediate translational value to clinical neonatology. ✅🌍 Authored by Seyed Rasoul Jalali📅 18 August 2025
Author: JALALI, SEYED RASOUL
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7075848676
FWCI:
Cites:
Cited by:
Related to: